Shantou Institute of Ultrasonic Instrument
301602
Hubei Sinophorus Electronic Materials
688545
Pansoft
300996
4
Jiayu Holding
300117
5
Wuxi Taclink Optoelectronics Technology
688205
US Stock MarketDetailed Quotes
TNXP Tonix Pharmaceuticals
- 0.2389
- +0.0034+1.44%
Close Jan 21 16:00 ET
- 0.2355
- -0.0034-1.42%
Pre 05:18 ET
44.65MMarket Cap0.00P/E (TTM)
0.2389High0.2222Low36.91MVolume0.2355Open0.2355Pre Close8.45MTurnover19.75%Turnover Ratio0.00P/E (Static)186.89MShares12.480052wk High0.60P/B44.65MFloat Cap0.118052wk Low--Dividend TTM186.89MShs Float263679868.1600Historical High--Div YieldTTM7.09%Amplitude0.1180Historical Low0.2290Avg Price1Lot Size
About Tonix Pharmaceuticals Company
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.
Company Profile
SymbolTNXP
Company NameTonix Pharmaceuticals
Listing DateAug 9, 2013
Founded2007
CEODr. Seth Lederman, M.D.
MarketNASDAQ
Employees103
Fiscal Year Ends12-31
Address26 Main Street,Suite 101
CityChatham
ProvinceNew Jersey
CountryUnited States of America
Zip Code07928
Phone1-862-799-8599
Websitehttp://www.tonixpharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Seth Lederman, M.D.
- Chairman of the Board, President and Chief Executive Officer
- 2.05M
- Jessica Edgar Morris
- Chief Operating Officer
- 928.60K
- Dr. Gregory M. Sullivan, M.D.
- Chief Medical Officer and Secretary
- 952.00K
- Bradley Saenger, C.P.A.
- Chief Financial Officer, Principal Accounting Officer and Treasurer
- 904.91K
- Margaret Smith Bell
- Independent Director
- 82.48K
- James Treco
- Lead Independent Director
- 102.48K
- Dr. Adeoye Y. Olukotun, M.D.
- Independent Director
- 82.48K
- Richard H. Bagger
- Independent Director
- 82.48K
- Richard Newcomb Stillwell
- Independent Director
- 113.05K
- General David L. Grange
- Independent Director
- 82.48K
- Carolyn E. Taylor
- Independent Director
- 82.48K
Trending Stocks
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Stocks & Industries to Watch Under Trump's Second Presidency
Key takeaways Tech stocks underwent substantial growth due to tax cuts and reduced corporate regulations in Trump's first term along with defense and aerospace
Discussing
December CPI comes in as expected, is that enough?
U.S. December CPI rose 2.9% year-on-year, aligning with expectations but marking a three-month inflation increase trend. The market reacted
In One Chart
Jan 15 22:05
Here's the Breakdown for December CPI, in One Chart